ALEC

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Alector Inc

NASDAQ | ALEC

1.20

USD

$0.00

(

0.00%

)

At Close (As of Nov 20, 2025)

$133.17M

Market Cap

-

P/E Ratio

-1.06

EPS

$4.18

52 Week High

$0.87

52 Week Low

HEALTHCARE

Sector

ALEC Chart

Recent Chart
Price Action

ALEC Technicals

Tags:

ALEC Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $101M
Total Revenue $101M
Cost Of Revenue $8.8M
Costof Goods And Services Sold $8.8M
Operating Income -$145M
Selling General And Administrative $60M
Research And Development $186M
Operating Expenses $246M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.8M
Income Before Tax -$119M
Income Tax Expense $128K
Interest And Debt Expense -
Net Income From Continuing Operations -$119M
Comprehensive Income Net Of Tax -
Ebit -$145M
Ebitda -$136M
Net Income -$119M

Revenue & Profitability

Earnings Performance

ALEC Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $468M
Total Current Assets $425M
Cash And Cash Equivalents At Carrying Value $33M
Cash And Short Term Investments $33M
Inventory -
Current Net Receivables -
Total Non Current Assets $43M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $380M
Other Current Assets $11M
Other Non Current Assets -
Total Liabilities $342M
Total Current Liabilities $125M
Current Accounts Payable $2.2M
Deferred Revenue -
Current Debt -
Short Term Debt $8.8M
Total Non Current Liabilities $216M
Capital Lease Obligations $33M
Long Term Debt $9.4M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $43M
Other Current Liabilities $90M
Other Non Current Liabilities $1.2M
Total Shareholder Equity $127M
Treasury Stock -
Retained Earnings -$829M
Common Stock $9K
Common Stock Shares Outstanding $97M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$230M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $8.8M
Capital Expenditures $1.3M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $107M
Cashflow From Financing $82M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$119M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $101M
Total Revenue $101M
Cost Of Revenue $8.8M
Costof Goods And Services Sold $8.8M
Operating Income -$145M
Selling General And Administrative $60M
Research And Development $186M
Operating Expenses $246M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.8M
Income Before Tax -$119M
Income Tax Expense $128K
Interest And Debt Expense -
Net Income From Continuing Operations -$119M
Comprehensive Income Net Of Tax -
Ebit -$145M
Ebitda -$136M
Net Income -$119M

ALEC News

ALEC Profile

Alector Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Alector, Inc. (ALEC) is a leading clinical-stage biopharmaceutical firm focused on creating breakthrough therapies for neurodegenerative diseases such as Alzheimer's and frontotemporal dementia. The company harnesses its innovative immuno-neurology platform to engage the immune system in revitalizing neuronal health and function. Headquartered in South San Francisco, Alector is committed to advancing the treatment landscape within neurology, showcased by a robust pipeline of differentiated product candidates that hold the potential to significantly alter the course of these challenging conditions.

LPTX
+368.57%
$2.05
SOND
+79.15%
$0.16
BNKK
+19.70%
$0.17
NVDA
-3.15%
$180.64
IVP
+18.43%
$0.12
VHAI
-50.00%
$0.00
ONDS
-16.40%
$6.27
TSLA
-2.16%
$395.23
PLUG
-0.52%
$1.89
BYND
-9.80%
$0.88
WTO
-14.65%
$0.01
ASST
-6.40%
$0.98
SOFI
-6.77%
$24.91
INTC
-4.24%
$33.62
F
-3.79%
$12.41
SGBX
-37.06%
$3.82
CIFR
-0.41%
$14.56
GRAB
-6.21%
$4.98
VIVK
-9.58%
$0.11
BITF
0.00%
$2.60
PLTR
-5.84%
$155.74
AIIO
+41.76%
$0.78
NWTN
+41.76%
$0.78
DNN
-4.52%
$2.32
WULF
-5.47%
$11.56
NVVE
-15.67%
$0.16
ACHR
-8.03%
$6.87
NIO
-6.08%
$5.40
MNDR
+83.13%
$3.04
EXAS
+16.81%
$100.67
AXDX
-61.36%
$0.03
AMD
-7.84%
$206.02
AUID
+5.55%
$1.71
IREN
-5.14%
$43.47
GOOGL
-1.14%
$289.45
BMNR
-10.82%
$26.02
AAL
-0.72%
$12.24
NOK
-2.65%
$5.87
MARA
-7.74%
$10.24
DVLT
+8.75%
$1.74
SOUN
-2.92%
$11.29
RGTI
-10.44%
$22.80
PFE
-1.92%
$24.40
ADAP
-15.14%
$0.05
WMT
+6.46%
$107.11
AMZN
-2.49%
$217.14
SNAP
-3.11%
$7.78
MU
-10.86%
$201.37
WBD
-0.90%
$22.88
CHR
-7.57%
$0.05
AAPL
-0.86%
$266.25
RIVN
-0.40%
$14.66
RIG
-6.34%
$3.84
EOSE
+0.78%
$12.88
ABEV
-1.61%
$2.43
NFE
+25.86%
$1.46
T
+0.98%
$25.52
PLTD
+5.82%
$7.63
AZI
-18.11%
$0.06
BURU
-10.54%
$0.18
HOOD
-10.11%
$106.21
TLRY
-6.53%
$0.89
UBER
-6.89%
$83.36
BBWI
-24.80%
$15.82
CRWV
-7.62%
$69.21
QBTS
-12.50%
$20.51
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
RXRX
-4.46%
$3.85
PCG
+0.76%
$15.84
APLD
-7.44%
$21.37
ADD
-25.47%
$0.05
SMCI
-6.43%
$31.56
CAN
-4.08%
$0.92
NFLX
-3.93%
$105.67
CYPH
0.00%
$2.94
BBD
-1.69%
$3.48
BAC
-1.96%
$51.00
NBIS
-10.97%
$84.64
BTBT
-5.09%
$2.05
IONZ
+28.40%
$6.42
BULL
+0.36%
$8.25
SRM
+53.27%
$10.30
QUBT
-11.15%
$10.27
GOOG
-1.02%
$289.98
IONQ
-14.36%
$41.00
BTG
-4.53%
$3.79
LEN
+0.94%
$116.25
NVTS
-2.20%
$7.55
LAES
-7.86%
$3.63
VZ
-1.04%
$40.76
PLTZ
+11.57%
$8.48
SMR
-11.50%
$18.70
RZLV
-0.66%
$2.99
VALE
-1.65%
$11.92
BTE
-0.62%
$3.16
CLSK
-4.30%
$9.78
BMNU
-22.39%
$5.37
CGC
-3.80%
$1.01
HBAN
-0.39%
$15.32
LPTX
+368.57%
$2.05
SOND
+79.15%
$0.16
BNKK
+19.70%
$0.17
NVDA
-3.15%
$180.64
IVP
+18.43%
$0.12
VHAI
-50.00%
$0.00
ONDS
-16.40%
$6.27
TSLA
-2.16%
$395.23
PLUG
-0.52%
$1.89
BYND
-9.80%
$0.88
WTO
-14.65%
$0.01
ASST
-6.40%
$0.98
SOFI
-6.77%
$24.91
INTC
-4.24%
$33.62
F
-3.79%
$12.41
SGBX
-37.06%
$3.82
CIFR
-0.41%
$14.56
GRAB
-6.21%
$4.98
VIVK
-9.58%
$0.11
BITF
0.00%
$2.60
PLTR
-5.84%
$155.74
AIIO
+41.76%
$0.78
NWTN
+41.76%
$0.78
DNN
-4.52%
$2.32
WULF
-5.47%
$11.56
NVVE
-15.67%
$0.16
ACHR
-8.03%
$6.87
NIO
-6.08%
$5.40
MNDR
+83.13%
$3.04
EXAS
+16.81%
$100.67
AXDX
-61.36%
$0.03
AMD
-7.84%
$206.02
AUID
+5.55%
$1.71
IREN
-5.14%
$43.47
GOOGL
-1.14%
$289.45
BMNR
-10.82%
$26.02
AAL
-0.72%
$12.24
NOK
-2.65%
$5.87
MARA
-7.74%
$10.24
DVLT
+8.75%
$1.74
SOUN
-2.92%
$11.29
RGTI
-10.44%
$22.80
PFE
-1.92%
$24.40
ADAP
-15.14%
$0.05
WMT
+6.46%
$107.11
AMZN
-2.49%
$217.14
SNAP
-3.11%
$7.78
MU
-10.86%
$201.37
WBD
-0.90%
$22.88
CHR
-7.57%
$0.05
AAPL
-0.86%
$266.25
RIVN
-0.40%
$14.66
RIG
-6.34%
$3.84
EOSE
+0.78%
$12.88
ABEV
-1.61%
$2.43
NFE
+25.86%
$1.46
T
+0.98%
$25.52
PLTD
+5.82%
$7.63
AZI
-18.11%
$0.06
BURU
-10.54%
$0.18
HOOD
-10.11%
$106.21
TLRY
-6.53%
$0.89
UBER
-6.89%
$83.36
BBWI
-24.80%
$15.82
CRWV
-7.62%
$69.21
QBTS
-12.50%
$20.51
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
RXRX
-4.46%
$3.85
PCG
+0.76%
$15.84
APLD
-7.44%
$21.37
ADD
-25.47%
$0.05
SMCI
-6.43%
$31.56
CAN
-4.08%
$0.92
NFLX
-3.93%
$105.67
CYPH
0.00%
$2.94
BBD
-1.69%
$3.48
BAC
-1.96%
$51.00
NBIS
-10.97%
$84.64
BTBT
-5.09%
$2.05
IONZ
+28.40%
$6.42
BULL
+0.36%
$8.25
SRM
+53.27%
$10.30
QUBT
-11.15%
$10.27
GOOG
-1.02%
$289.98
IONQ
-14.36%
$41.00
BTG
-4.53%
$3.79
LEN
+0.94%
$116.25
NVTS
-2.20%
$7.55
LAES
-7.86%
$3.63
VZ
-1.04%
$40.76
PLTZ
+11.57%
$8.48
SMR
-11.50%
$18.70
RZLV
-0.66%
$2.99
VALE
-1.65%
$11.92
BTE
-0.62%
$3.16
CLSK
-4.30%
$9.78
BMNU
-22.39%
$5.37
CGC
-3.80%
$1.01
HBAN
-0.39%
$15.32
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.